n,n-dimethylarginine has been researched along with Polycystic Ovarian Syndrome in 22 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (22.73) | 29.6817 |
| 2010's | 15 (68.18) | 24.3611 |
| 2020's | 2 (9.09) | 2.80 |
| Authors | Studies |
|---|---|
| Gao, H; Li, T; Liu, R; Wang, H; Yin, C; Zhang, Q; Zhang, T | 1 |
| Alipoor, E; Asghari, S; Hosseinzadeh-Attar, MJ; Mohammad Hosseinzadeh, F; Rashidi, BH; Yekaninejad, MS | 1 |
| Javn, SB; Loganathan, S; Mala, K; Ramachandran, S; Sundari, M; Thomas, S | 1 |
| Dsilva, B; Joseph, A; Krishna, MB; Laloraya, M; Pillai, SM; Thomas, PL | 1 |
| Akdeniz, D; Carlioglu, A; Gumus, II; Karakurt, F; Kaygusuz, I; Uz, B | 1 |
| Bayraktar, N; Göktaş, T; Gülcan Kurt, Y; Güler, İ; Hımmetoğlu, MÖ; Kiliç, N; Taner, MZ; Taşlipinar, A; Yaman, H; Yavuz Taşlipinar, M | 1 |
| Hutchison, SK; McGrath, BP; Meyer, C; Moran, LJ; Teede, HJ; Zoungas, S | 1 |
| Ciftci, O; Demirag, NG; Ertugrul, D; Kulaksizoglu, M; Kulaksizoglu, S; Pamuk, BO; Torun, AN; Yildirim, E | 1 |
| Engin-Üstün, Y; Kafkasli, A; Kali, Z; Karabulut, AB; Meydanli, M; Turan, F; Türkçüoğlu, I | 1 |
| Aydin, M; Batioglu, S; Erdogan, G; Kilic, S; Yilmaz, N; Zulfikaroglu, E | 1 |
| Bayrak, A; Bayrak, T; Cakir, E; Noyan, V; Sagsoz, N; Soyman, Z; Tulmac, M; Yucel, A | 1 |
| Adali, E; Bugdayci, G; Ilhan, GA; Kolusari, A; Yildizhan, B; Yildizhan, R | 1 |
| Cameron, JD; Moran, LJ; Strauss, BJ; Teede, HJ | 1 |
| Brinkworth, GD; Buckley, JD; Clifton, PM; Noakes, M; Norman, RJ; Thomson, RL | 1 |
| Bayrak, A; Bayrak, T; Cakır, E; Dursun, P; Gültekin, M; Kolusarı, A; Ozyurt, M; Zeyneloğlu, HB | 1 |
| Cho, S; Choi, YS; Jeon, YE; Jung, JA; Kim, HY; Lee, BS; Seo, SK; Yang, HI | 1 |
| Clifton, PM; Moran, LJ; Noakes, M; Norman, RJ; Wittert, GA | 1 |
| Charitidou, C; Farmakiotis, D; Hatzistilianou, M; Karamanis, N; Katsikis, I; Panidis, D; Pegiou, T; Pidonia, I; Zournatzi, V | 1 |
| Biberoğlu, G; Bideci, A; Camurdan, MO; Cinaz, P; Demirel, F; Hasanoğlu, A; Yesilkaya, E | 1 |
| Heutling, D; Kaltwasser, P; Kleinstein, J; Krzyzanowska, K; Lehnert, H; Mittermayer, F; Nickel, I; Randeva, H; Schernthaner, G; Schulz, H; Westphal, S; Wolzt, M | 1 |
| Nelson, SM; Sattar, N | 1 |
| Baser, I; Dede, M; Erbil, MK; Kenar, L; Oktenli, C; Ozgurtas, T; Sanisoglu, SY; Tapan, S; Yenen, MC; Yesilova, Z | 1 |
1 review(s) available for n,n-dimethylarginine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Polycystic ovarian syndrome-associated cardiovascular complications: An overview of the association between the biochemical markers and potential strategies for their prevention and elimination.
Topics: Arginine; Biomarkers; Cardiovascular Diseases; Female; Glycation End Products, Advanced; Homocysteine; Humans; Oxidative Stress; Polycystic Ovary Syndrome; Receptor for Advanced Glycation End Products; von Willebrand Factor | 2017 |
6 trial(s) available for n,n-dimethylarginine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
Effects of Selenium Supplementation on Asymmetric Dimethylarginine and Cardiometabolic Risk Factors in Patients with Polycystic Ovary Syndrome.
Topics: Adolescent; Adult; Arginine; Cardiometabolic Risk Factors; Dietary Supplements; Double-Blind Method; Female; Humans; Middle Aged; Polycystic Ovary Syndrome; Selenium; Testosterone; Young Adult | 2020 |
Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.
Topics: Adult; Arginine; Biomarkers; Blood Glucose; C-Reactive Protein; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Cyproterone Acetate; Drug Therapy, Combination; Endothelium, Vascular; Ethinyl Estradiol; Female; Humans; Hyperandrogenism; Hypoglycemic Agents; Inflammation Mediators; Insulin; Insulin Resistance; Lipids; Metformin; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Sex Hormone-Binding Globulin; Testosterone; Time Factors; Treatment Outcome; Vasodilation; von Willebrand Factor | 2010 |
Inflammatory-metabolic parameters in obese and nonobese normoandrogenemic polycystic ovary syndrome during metformin and oral contraceptive treatment.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Contraceptives, Oral; Female; Homocysteine; Humans; Hypoglycemic Agents; Insulin Resistance; Metformin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Young Adult | 2011 |
Serum retinol-binding protein 4, leptin, and plasma asymmetric dimethylarginine levels in obese and nonobese young women with polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Female; Humans; Leptin; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Retinol-Binding Proteins, Plasma; Young Adult | 2011 |
The effect of diet and exercise on markers of endothelial function in overweight and obese women with polycystic ovary syndrome.
Topics: Adult; Arginine; Body Mass Index; Cardiovascular Diseases; Diet; Endothelium, Vascular; Exercise; Exercise Therapy; Female; Humans; Insulin Resistance; Intercellular Adhesion Molecule-1; Overweight; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Risk; Vascular Cell Adhesion Molecule-1 | 2012 |
The administration of estrogens, combined with anti-androgens, has beneficial effects on the hormonal features and asymmetric dimethyl-arginine levels, in women with the polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cyproterone Acetate; Desogestrel; Drug Therapy, Combination; Endothelin-1; Estradiol; Estrogens; Estrogens, Conjugated (USP); Ethinyl Estradiol; Female; Hormones; Humans; Insulin Resistance; Polycystic Ovary Syndrome | 2008 |
15 other study(ies) available for n,n-dimethylarginine and Polycystic Ovarian Syndrome
| Article | Year |
|---|---|
The ADMA-DDAH1 axis in ovarian apoptosis of polycystic ovary syndrome.
Topics: Amidohydrolases; Animals; Apoptosis; Arginine; Dehydroepiandrosterone; Female; Humans; Polycystic Ovary Syndrome; Rats; Rats, Sprague-Dawley; Signal Transduction | 2023 |
Impaired Arginine Metabolism Coupled to a Defective Redox Conduit Contributes to Low Plasma Nitric Oxide in Polycystic Ovary Syndrome.
Topics: Amidohydrolases; Arginine; Argininosuccinate Lyase; Cationic Amino Acid Transporter 1; Female; Humans; Hydrogen Peroxide; Nitrates; Nitric Oxide; Nitric Oxide Synthase Type II; Nitric Oxide Synthase Type III; Nitrites; Oxidation-Reduction; Polycystic Ovary Syndrome; Protein-Arginine N-Methyltransferases; Repressor Proteins | 2017 |
Effect of ethinyl estradiol-cyproterone acetate treatment on asymmetric dimethyl-arginine levels in women with polycystic ovary syndrome.
Topics: Adult; Androgen Antagonists; Arginine; Cholesterol, LDL; Cyproterone Acetate; Drug Combinations; Ethinyl Estradiol; Female; Glucose; Humans; Insulin Resistance; Lipid Metabolism; Polycystic Ovary Syndrome; Prospective Studies; Young Adult | 2014 |
Endothelial dysfunction and insulin resistance in young women with polycystic ovarian syndrome.
Topics: Adult; Arginine; Body Mass Index; Endothelium, Vascular; Female; Humans; Insulin Resistance; Nitric Oxide; Polycystic Ovary Syndrome; Young Adult | 2014 |
Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.
Topics: Adolescent; Adult; Arginine; Energy Metabolism; Female; Humans; Obesity; Polycystic Ovary Syndrome; Prospective Studies; Tunica Intima; Tunica Media; Ultrasonography; Young Adult | 2010 |
Evaluation of asymmetric dimethylarginine, nitric oxide levels and associated independent variables in obese and lean patients with polycystic ovarian syndrome.
Topics: Adolescent; Adult; Arginine; Biomarkers; Blood Glucose; Cardiovascular Diseases; Cholesterol; Female; Hormones; Humans; Nitric Oxide; Obesity; Polycystic Ovary Syndrome; Risk Factors; Young Adult | 2011 |
Serum paraoxonase 1 activity, asymmetric dimethylarginine levels, and brachial artery flow-mediated dilatation in women with polycystic ovary syndrome.
Topics: Adult; Arginine; Aryldialkylphosphatase; Biomarkers; Blood Flow Velocity; Brachial Artery; Case-Control Studies; Endothelium, Vascular; Female; Hormones; Humans; Polycystic Ovary Syndrome; Prospective Studies; Risk Factors; Ultrasonography; Vasodilation; Young Adult | 2011 |
Vascular function in the diagnostic categories of polycystic ovary syndrome.
Topics: Adult; Arginine; C-Reactive Protein; Cardiovascular Diseases; Cross-Sectional Studies; Endothelium, Vascular; Female; Humans; Insulin Resistance; Overweight; Phenotype; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Resistance | 2011 |
Paraoxonase lactonase activity (PON-HTLase), asymmetric dimethylarginine (ADMA) and platelet activating factor-acetylhydrolase (PAF-AH) activity in non-obese women with PCOS.
Topics: 1-Alkyl-2-acetylglycerophosphocholine Esterase; Adolescent; Adult; Arginine; Aryldialkylphosphatase; Body Mass Index; Case-Control Studies; Female; Humans; Obesity; Polycystic Ovary Syndrome; Young Adult | 2012 |
Serum asymmetric dimethylarginine, apelin, and tumor necrosis factor-α levels in non-obese women with polycystic ovary syndrome.
Topics: Apelin; Arginine; Body Mass Index; Case-Control Studies; Female; Humans; Hyperandrogenism; Intercellular Signaling Peptides and Proteins; Polycystic Ovary Syndrome; Tumor Necrosis Factor-alpha; Young Adult | 2012 |
Weight loss and vascular inflammatory markers in overweight women with and without polycystic ovary syndrome.
Topics: Adult; Arginine; Biomarkers; Cardiovascular Diseases; Female; Humans; Intercellular Adhesion Molecule-1; Plasminogen Activator Inhibitor 1; Polycystic Ovary Syndrome; Vascular Cell Adhesion Molecule-1; Waist Circumference; Weight Loss | 2012 |
Serum leptin, oxidized low density lipoprotein and plasma asymmetric dimethylarginine levels and their relationship with dyslipidaemia in adolescent girls with polycystic ovary syndrome.
Topics: Adolescent; Apolipoproteins B; Arginine; Biomarkers; Case-Control Studies; Cholesterol; Cholesterol, LDL; Dyslipidemias; Female; Humans; Leptin; Lipoprotein(a); Lipoproteins, LDL; Lipoproteins, VLDL; Multivariate Analysis; Obesity; Polycystic Ovary Syndrome; Triglycerides | 2007 |
Asymmetrical dimethylarginine, inflammatory and metabolic parameters in women with polycystic ovary syndrome before and after metformin treatment.
Topics: Adult; Androgens; Arginine; Blood Glucose; Body Mass Index; C-Reactive Protein; Cholesterol, LDL; Cross-Sectional Studies; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Statistics, Nonparametric; Triglycerides; Waist-Hip Ratio | 2008 |
Polycystic ovarian syndrome, biomarkers, and metformin: research, risk, and reality.
Topics: Arginine; Female; Humans; Hypoglycemic Agents; Metformin; Polycystic Ovary Syndrome; Risk Factors | 2008 |
Metformin and oral contraceptive treatments reduced circulating asymmetric dimethylarginine (ADMA) levels in patients with polycystic ovary syndrome (PCOS).
Topics: Adult; Androgens; Arginine; Body Mass Index; Case-Control Studies; Contraceptives, Oral; Cyproterone Acetate; Ethinyl Estradiol; Female; Gonadotropins; Humans; Insulin Resistance; Metformin; Polycystic Ovary Syndrome; Time Factors | 2008 |